ConductScience.org, home

Gene · 5891

Papers1,940

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Preliminary Evidence of Blood DNA Methylation Changes in Pregnant Women Adhering to a Mediterranean Diet.Epigenomes202641718410PubTator, text miningPubMed
Pulpitis as a microbial disease: single-cell insights into host responses and diagnostic biomarkers for vital pulp therapy.J Oral Microbiol202641717505PubTator, text miningPubMed
Synergistic effects of radiotherapy and immunotherapy: improving oncological outcomes.Front Immunol202641716387PubTator, text miningPubMed
Neutrophils in the hepatocellular carcinoma microenvironment: orchestrators of progression and immunity.Front Immunol202641710884PubTator, text miningPubMed
Exploring the Mechanism of Therapeutic Effects of Polydatin in Lung Ischemia-Reperfusion Injury by Network Pharmacology and Experiment Validation.J Inflamm Res202641709960PubTator, text miningPubMed
Interaction between HIV-1 Tat and EBV Zta favours immune escape of B cells by downregulating HLA-ABC expression.Cell Mol Life Sci202641627500PubTator, text miningPubMed
NRF1 and NRF2 Expression in Preeclamptic Placentas: A Comparative Observational Study.Life (Basel)202641598244PubTator, text miningPubMed
Study of the multitarget mechanism of Zao Ren Gan Cao Da Mai decoction in the treatment of insomnia comorbid with depression based on network pharmacology and molecular docking technology.Medicine (Baltimore)202641578589PubTator, text miningPubMed
Temporal microRNA changes and their functional significance during vascular calcification: an integrative trajectory-based analysis.Int J Biol Macromol202641577277PubTator, text miningPubMed
Exploring the Mechanism of Qigesan in Treating Esophageal Carcinoma Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.Curr Comput Aided Drug Des202641572715PubTator, text miningPubMed
First-in-human study to investigate the safety and efficacy of effective-mononuclear cell therapy for radiogenic xerostomia.Regen Ther202641567729PubTator, text miningPubMed
Hepatocyte-hepatic stellate cell interactions in liver fibrosis: Mechanisms and therapeutic implications.Hepatol Commun202641564388PubTator, text miningPubMed
Prediction of primary human targets and toxicity mechanisms of imidacloprid using integrative In Silico approaches.Toxicol Rep202641550879PubTator, text miningPubMed
Oxidative stress-driven transcriptomic remodeling in human astrocytes reveals network signatures associated with neurodegenerative and cardiovascular processes.Comput Struct Biotechnol J202641550140PubTator, text miningPubMed
Exploring the mechanism of Kemofang in treating idiopathic membranous nephropathy based on LC-MS/MS combined with network pharmacology, molecular docking, and molecular dynamics simulation.Sci Rep202641535312PubTator, text miningPubMed
Shedding light on the function of autophagy in complicated pregnancies.Cell Death Dis202641507150PubTator, text miningPubMed
Integrative Network Pharmacology and Molecular Docking-Based Validation of Berberine as a Therapeutic Agent in Arsenic-Induced Cardiotoxicity.Cardiovasc Toxicol202641489701PubTator, text miningPubMed
CircANKRD36 Knockdown Inhibits M1 Polarization and Inflammatory Response via miR-498/TXNRD1 in LPS-Stimulated Macrophages Under High Glucose Conditions.J Biochem Mol Toxicol202641468248PubTator, text miningPubMed
Type 3 Diabetes: A Molecular Link Between Cerebral Insulin Resistance and Neurodegeneration via AGE-RAGE Signaling.Eur J Neurosci202641459736PubTator, text miningPubMed
Signaling complexity in diabetic neuropathy: a multitargeted perspective on pathogenesis and therapy.J Recept Signal Transduct Res202641422384PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5891/papers?page=4